Stay updated on Pembrolizumab with BCG in HR NMIBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.

Latest updates to the Pembrolizumab with BCG in HR NMIBC Clinical Trial page
- Check2 days agoChange DetectedThe page revision tag was bumped from v3.6.6 to v3.7.0, indicating a new deployment of the page. This update does not alter the study information or user-facing content.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page's revision marker was updated from v3.6.5 to v3.6.6, signaling a minor update to the page's version.SummaryDifference0.0%

- Check23 days agoChange Detected2018 ( U.S. NIH Grant/Contract ) was added to the study's funding information, indicating NIH support for the trial in 2018.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision: v3.6.5 has been added to the page, replacing the former v3.6.4 version. The Plain Language Summary section has been removed.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a backend/content-management update.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page's revision tag was updated from Revision: v3.6.0 to Revision: v3.6.3 to reflect a newer version.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with BCG in HR NMIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.